| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/16/2002 | US20020058048 Contains a nonionic, amphoteric or cationic surfactant in an amount effective to eliminate or substantially ameliorate burning pain caused by capsaicin. |
| 05/16/2002 | US20020058047 Vaccines |
| 05/16/2002 | US20020058040 Injectable vaccine composition comprising an immunogenic conjugate in a water in oil emulsion; enhanced immunogenicity after storage at about -18 degrees C. |
| 05/16/2002 | US20020058023 Apoptotic bodies and/or apoptotic cells are in a liquid suspension along with viable cells. |
| 05/16/2002 | US20020058021 Plasmid containing a nucleotide sequence encoding an immunogen of a pathogen to allow in vivo expression of this sequence, and as a cationic lipid, 2,3-di-c12-18-alkoxy-N-(amino- or hydroxyalkyl)-N,N-dimethylpropylammonium salt |
| 05/16/2002 | US20020058012 Gum matrix having spaces within the gum matrix; size and/or morphology of spaces determined by size and/or morphology of crystals of an entrapped frozen liquid present during manufacture |
| 05/16/2002 | US20020058011 Aerosol formulation containing particulate formoterol, propellant and polar cosolvent |
| 05/16/2002 | US20020058009 Pulmonary delivery in treating disorders of the central nervous system |
| 05/16/2002 | US20020056206 Spray drying process and compositions of fenofibrate |
| 05/16/2002 | DE10056136A1 Inhibiting leukocyte or tumor cell adhesion to vascular endothelial cells e.g. for combating inflammation or metastasis, using e.g. pregnancy proteins or selectin binding liposomes containing calcium-binding compound |
| 05/16/2002 | DE10056014A1 Laminated plaster with active substance, used as transdermal therapeutic system, has impermeable barrier layer on side away from skin and separable carrier layer with adhesive on side towards skin |
| 05/16/2002 | DE10056012A1 Carrier material for medical applications, preferably for transdermal therapeutic system, has aluminum film between carrier and self-adhesive coating |
| 05/16/2002 | DE10056011A1 Well tolerated plaster for controlled delivery of essential oils to skin or air, has active agent containing matrix comprising polyisobutylene, amorphous poly-alpha-olefin and optionally filler |
| 05/16/2002 | DE10056009A1 Well tolerated plaster for controlled delivery of hyperemic agents, having active agent-containing matrix comprising polyisobutylene, amorphous poly-alpha-olefin and filler |
| 05/16/2002 | DE10054919A1 Topical analgesic and antipruritic medicament, useful e.g. for combating pain of injections, comprising local anesthetic in colloidal carrier system comprising lipophilic and hydrophobic phases |
| 05/16/2002 | DE10054702A1 Gemisch zur Behandlung der Haut Mixture for treating the skin |
| 05/16/2002 | DE10054641A1 Verwendung einer Zubereitung von Cimicifuga racemosa Use of a preparation of Cimicifuga racemosa |
| 05/16/2002 | DE10053053A1 Pharmazeutische Formulierungen zur Hemmung von entzündlichen Arthritiden Pharmaceutical formulations for inhibition of inflammatory arthritis |
| 05/16/2002 | DE10048510A1 Lagerstabile Infusionslösung des Ciprofloxacins mit verringertem Säuregehalt A storage-stable infusion of ciprofloxacin with reduced acidity |
| 05/16/2002 | CA2429012A1 New pharmaceutical compositions based on tiotropium salts and salts of salmeterol |
| 05/16/2002 | CA2428784A1 Oral pharmaceutical composition containing a block copolymer |
| 05/16/2002 | CA2428207A1 Therapeutic agents for keratoconjunctival diseases comprising farnesylacetic acid as active ingredient |
| 05/16/2002 | CA2428181A1 Pharmaceutical preparation of percutaneous absorption type |
| 05/16/2002 | CA2428179A1 Compositions of n-(methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides |
| 05/16/2002 | CA2428159A1 Delayed-release pharmaceutical formulations containing proinsulin c-peptide |
| 05/16/2002 | CA2428141A1 Use of selectin-binding pregnancy proteins, liposomes, native mucin fragments and mimetic compounds for the treatment and prophylaxis of inflammatory diseases, for preventing metastatic spread and for the prophylaxis of tumour diseases |
| 05/16/2002 | CA2428103A1 Vaccines with enhanced immune response and methods for their preparation |
| 05/16/2002 | CA2427283A1 Device and method for the cessation of smoking |
| 05/16/2002 | CA2425688A1 Extended release erythromycin derivatives |
| 05/16/2002 | CA2425594A1 Compositions containing hydrolytically unstable compounds |
| 05/15/2002 | EP1205190A1 Stable medicinal compositions for oral use |
| 05/15/2002 | EP1205183A2 Antimicrobial composition containing cellulose acetate |
| 05/15/2002 | EP1205181A2 Composition and method for parenteral administration of ibuprofen D, L-or L-Lysine salt |
| 05/15/2002 | EP1205180A2 Delivery system for hydrophobic drugs |
| 05/15/2002 | EP1205175A1 Hair mousse with long-lasting effect |
| 05/15/2002 | EP1204761A2 Targeted artificial gene delivery |
| 05/15/2002 | EP1204699A1 Pullulan film compositions |
| 05/15/2002 | EP1204670A2 Antibiotic agents |
| 05/15/2002 | EP1204432A1 Plaster for introducing pharmaceutical compositions in living organisms |
| 05/15/2002 | EP1204429A2 Sustained release formulation of a peptide |
| 05/15/2002 | EP1204428A2 Targeted lipid particles |
| 05/15/2002 | EP1204427A1 The nasal transmucosal delivery of peptides conjugated with biocompatible polymers |
| 05/15/2002 | EP1204417A2 Parenteral cisplatin emulsion |
| 05/15/2002 | EP1204416A1 Carnitine analogues as topical, microbicidal spermicides |
| 05/15/2002 | EP1204410A1 Multi-component pharmaceutical dosage form |
| 05/15/2002 | EP1204409A1 Microparticles for pulmonary administration |
| 05/15/2002 | EP1204407A2 Implantable active ingredient depot |
| 05/15/2002 | EP1204406A2 Opioid sustained-released formulation |
| 05/15/2002 | EP1204360A2 Personal care articles |
| 05/15/2002 | EP1204321A2 Super-active porcine growth hormone releasing hormone analog |
| 05/15/2002 | EP1161247A4 Method for the treatment of severe chronic bronchitis (bronchiectasis) with an aerosolized antibiotic |
| 05/15/2002 | EP1102594B1 Use of sodium chloride to reduce the gastrointestinal toxicity of camptothecin derivatives |
| 05/15/2002 | EP1091659B1 Oral form of administration |
| 05/15/2002 | EP1071401A4 Liposomal bupivacaine compositions and methods of preparation |
| 05/15/2002 | EP1066032B1 Sachet formulations |
| 05/15/2002 | EP1054686B1 Pharmaceutical formulation of a didemnin compound |
| 05/15/2002 | EP1032391B1 Spheroids containing tiagabine, preparation process and pharmaceutical compositions |
| 05/15/2002 | EP0868167B1 Desensitising toothpaste |
| 05/15/2002 | EP0730443B1 Suspension of loteprednol etabonate |
| 05/15/2002 | EP0688329B1 Novel phospholipid-saccharide conjugates |
| 05/15/2002 | EP0626850B1 Dry compositions for preparing submicron emulsions |
| 05/15/2002 | EP0617623B1 Transdermally administered system containing acetylsalicylic acid for thrombosis therapy |
| 05/15/2002 | CN2491018Y Portable medicinal plaster |
| 05/15/2002 | CN1349418A Compositions for treatment of disorders of the oesophagus |
| 05/15/2002 | CN1349409A Metabolic intervention with GLP-1 to improve the function of ischemic anc reperfused tissue |
| 05/15/2002 | CN1349404A Utilization of polycyclic 2-amino-thiazole systems in the production of medicaments for prophylaxis treatment of obesity |
| 05/15/2002 | CN1349402A Encapsulation of bioactive complexes in liposomes |
| 05/15/2002 | CN1349397A Intrauterine contraception with less side effects |
| 05/15/2002 | CN1348983A Kenrel oil composite extracted from plant kernel and its extraction process and application |
| 05/15/2002 | CN1348814A Chewing table capable of eliminating garlic smell in oral cavity |
| 05/15/2002 | CN1348809A Dressed plaster for treating Bell's palsy and its prepn |
| 05/15/2002 | CN1348802A Foot treating massage paste |
| 05/15/2002 | CN1348785A Medicine 'Xuewang' for treating anemia |
| 05/15/2002 | CN1348773A Chinese medicine navel melted tablet for treating menalgia and its prepn |
| 05/15/2002 | CN1348768A 活性山羊血粉胶囊 Activity goat blood meal capsule |
| 05/15/2002 | CN1348761A Targeting controlled-release microcapsule capable of inducing environment information quickly |
| 05/15/2002 | CN1348753A Carsickness and seasickness preventing medicated and magnetic watch and its usage |
| 05/15/2002 | CN1084626C Granulated prepn for promoting blood-circulation and removing blood stasis |
| 05/15/2002 | CN1084616C Coatings for tablet of paracetamol and domperidone |
| 05/15/2002 | CN1084614C Medicaments |
| 05/15/2002 | CN1084613C Aerosol prepn. |
| 05/15/2002 | CN1084612C Viracidal, bactericidal and spermicidal veginal suppository |
| 05/15/2002 | CN1084595C Utilizations of edible oil |
| 05/14/2002 | US6388047 Hydrophobic, hydrophilic macromolecules |
| 05/14/2002 | US6387978 Medical devices comprising ionically and non-ionically crosslinked polymer hydrogels having improved mechanical properties |
| 05/14/2002 | US6387918 A tricyclic compound (with oxy and nitrogen atoms in the ring); perticularly useful for treating or preventing psoriasis and other skin diseases |
| 05/14/2002 | US6387917 Nasal administering |
| 05/14/2002 | US6387889 Reducing ocular tension |
| 05/14/2002 | US6387886 Method for the treatment of severe chronic bronchitis (bronchietasis) with an aerosolized antibiotic |
| 05/14/2002 | US6387876 Covalent polar lipid-conjugates with biologically active compounds for use in salves |
| 05/14/2002 | US6387612 Method of preparing a terminally heat sterilized plasma-like solution |
| 05/14/2002 | US6387560 Nanostructured solid electrolytes and devices |
| 05/14/2002 | US6387416 Anti-Inflammatory herbal composition and method of use |
| 05/14/2002 | US6387414 Method for preparing hydroxyapatite composite and biocompatible material |
| 05/14/2002 | US6387412 Nutrients coated with magnesium oxychloride |
| 05/14/2002 | US6387411 Concurrent melting |
| 05/14/2002 | US6387410 Mixture containing nsaid, prostaglandin and one or more excipients |
| 05/14/2002 | US6387409 Composition and method of preparing microparticles of water-insoluble substances |
| 05/14/2002 | US6387408 Adhesive drug delivery composition |
| 05/14/2002 | US6387407 Topical drug preparations |